US Patent Issued to ModernaTX, Fundacion Para La Investigacion Medica Aplicada on Aug. 5 for "Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria" (American, Spanish Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,136, issued on Aug. 5, was assigned to ModernaTX Inc. (Cambridge, Mass.) and Fundacion Para La Investigacion Medica Aplicada (Pamplona, Spain).

"Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria" was invented by Paolo Martini (Boston), Stephen Hoge (Brookline, Mass.), Kerry Benenato (Sudbury, Mass.), Vladimir Presnyak (Manchester, N.H.), Lei Jiang (Cambridge, Mass.), Iain McFadyen (Arlington, Mass.), Ellalahewage Sathyajith Kumarasinghe (Harvard, Mass.), Antonio Fontanellas Roma (Pamplona, Spain), Pedro Berraondo Lopez (Pamplona, Spain), Matias Antonio Avila Zaragoza (Pamplona, Spain), Lin Tung Guey (Lexington, Mass.) and Staci Sab...